Failure to Administer and Document Diabetes Medications per Orders and Standards
Summary
The deficiency involves failures in medication administration and documentation for residents with type 2 diabetes. Facility policy on Medication Administration requires that medications be given in the correct dose, at the scheduled time, by the correct route, and that administration be documented in the MAR as soon as the medication is given, with a reason documented if a dose is omitted. The Medication Errors policy requires documentation of the rationale for each medication not administered. For one cognitively intact resident with type 2 diabetes, the order summary showed a standing order for a weekly subcutaneous Mounjaro injection starting in mid-November. The EMAR showed that the Mounjaro injections were not administered on two specific dates. The resident confirmed not receiving the injections on at least two occasions and expressed concern about the missed doses after a prior diabetes medication had been discontinued. There were no progress notes addressing the missed injections, no documentation of a medication error on the facility’s incident log, and no notification to the resident’s primary care provider. A second deficiency involved improper insulin administration technique using insulin pens. The facility’s clinical performance checklist for administering insulin via insulin pen requires attaching a new needle, priming the pen by dialing to 2 units and expelling insulin to remove air bubbles, and then administering the injection by inserting the needle, slowly depressing the injection knob, and holding the pen in place at the injection site for 6–10 seconds before removal. One resident with type 2 diabetes had orders for long-acting insulin in the morning and at night, and short-acting insulin on a sliding scale before meals and at bedtime based on blood glucose levels. During an observation of an LPN preparing and administering insulin to this resident, the LPN verified the ordered doses, cleaned the rubber stopper, dialed the correct units for both long-acting and short-acting insulin, and injected both doses into the resident’s upper arm. However, during this observed administration, the LPN did not prime either insulin pen before dialing up and injecting the ordered doses and did not hold either pen at the injection site for the required 6–10 seconds after depressing the plunger. The LPN later confirmed that neither pen had been primed and that the pens were not held in place after injection as required by the facility’s checklist. The DON confirmed that the resident with the missed Mounjaro injections did not receive the scheduled doses on the two identified dates, that there was no documentation in the progress notes regarding the missed injections, that the primary care provider was not notified, and that no incident or medication error report was filed for these events. The DON also confirmed that the facility’s expectation is that insulin pens be primed prior to use and held in place for at least 10 seconds after injection to ensure accurate dosing, which did not occur in the observed administration.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.